A selective, precise, and accurate method was developed for the determination of cimetidine (C), famotidine ( 
C imetidine (C), famotidine (F), and ranitidine hydrochloride (R·HCl) are listed in the British Pharmacopoeia (1). They are histamine H 2 -receptor antagonists that inhibit gastric acid secretions, and they are efficient in the treatment and prevention of recurrent duodenal ulcer (2, 3).
The structures of the 3 drugs are shown in Figure 1 . Several techniques have been used for the identification and determination of C, including titrimetry (4, 5), spectrophotometry (6, 7), fluorimetry (8) , colorimetry (9) , potentiometry (10) , capillary electrophoresis (CE; 11, 12) , voltammetry (13) , nuclear magnetic resonance spectrometry (14, 15) , infrared spectroscopy (16) , polarography (17) , thin-layer chromatography (TLC; 18), and liquid chromatography (LC; [19] [20] [21] . F has been determined by various techniques, including spectrophotometry (22) (23) (24) , fluorimetry (25) , flow injection analysis (26, 27) , CE (28) , polarography (29) , voltammetery (30) , potentiometry (31) , TLC (32, 33) , and LC (34) (35) (36) . R·HCl has been determined by spectrophotometry (37) (38) (39) , colorimetry (40, 41) , infrared spectroscopy (42) , flow injection analysis (43, 44) , voltammetry (45, 46) , potentiometry (47) , polarography (48) , CE (49, 50) , TLC (51) , and LC (20, (52) (53) (54) (55) .
C, F, and R·HCl contain sulfur atoms that make these drugs susceptible to atmospheric oxidation and photodegradation, resulting in the formation of sulfoxide derivatives (56) .
The purpose of the work described in this paper was to develop a simple, accurate, and rapid method for the assay of C, F, and R·HCl by high-performance thin-layer chromatography (HPTLC) in the presence of their sulfoxide derivatives in raw material and dosage forms.
Experimental

Reagents
All reagents were analytical grade and were used without further purification.
(a) Hydrochloric acid. (56) were prepared as stock solutions containing 10 mg/mL. A 1 g portion of each pure drug was weighed accurately, and each portion was transferred to a small conical flask and dissolved in 10 mL 0.1N HCl for C and F and in 10 mL water for R·HCl; 1 mL 30% hydrogen peroxide solution was added to each flask. The solutions were heated in a boiling water bath for 40 min for R·HCl and for 3 h for C and F; then each solution was quanti- tatively transferred to a 100 mL volumetric flask, and the contents of the flask were diluted to volume with water. (b) Working standard solutions.-A 2.5 mL aliquot of each stock standard solution was accurately transferred to a series of 10 mL volumetric flasks. The contents of each flask were diluted to volume with methanol for C and R·HCl and with water for F to produce a 2.5 mg/mL solution for C and a 1 mg/mL solution for F and R·HCl.
Preparation of Standard Solutions
Laboratory-Prepared Mixtures
Aliquots of the stock standard solutions equivalent to 5-45 mg C and 2-18 mg F and R·HCl were transferred to a series of 10 mL volumetric flasks and mixed with the degradates corresponding to 5-45 mg degraded C and 2-18 mg degraded F and R·HCl, respectively. The contents of each flask were diluted to volume with methanol for C and R·HCl and with water for F. This series contains 10-90% of the degradates.
Procedure
(a) Construction of calibration curves.-(1) For TLC.-Aliquots (2-20 µL) of each working standard solution were applied to a precoated 20 × 20 cm TLC plate by using a 25 µL syringe. Spots were spaced 2 cm apart and 1.5 cm from the bottom edge of the plate. Each plate was developed in a TLC tank previously saturated for $1 h with the mobile phase, i.e., ethyl acetate-isopropanol-20% ammonia (9 + 5 + 4, v/v) for C and F, and ethyl acetate-methanol-20% ammonia (10 + 2 + 2, v/v) for R·HCl; the plates were developed to a distance of 14-16 cm, and the developing time was ca 45 min. The plates were dried at room temperature, the spots were detected under a UV lamp, and the drugs were determined densitometrically (in flying-spot mode) at 218, 265, and 313 nm for C, F, and R·HCl, respectively. Calibration curves were constructed by plotting area under the peak versus concentration of the drug, and the second-order regression equations were calculated. (2) For HPTLC.-Aliquots (2-20 µL) of each working standard solution were applied to a precoated 10 × 20 cm HPTLC plate by using a 25 µL syringe. Spots were spaced 1 cm apart and 1.5 cm from the bottom edge of the plate. Each plate was developed in a TLC tank previously saturated for ≥1 h with the same mobile phase as was used in the TLC procedure. Each plate was developed to a distance of 7-8 cm, and the developing time was ca 45 min. Then the TLC procedure was followed, starting from "The plates were dried . . .". (b) Assay of laboratory-prepared mixtures.-A 10 µL aliquot of each laboratory-prepared mixture was applied to an HPTLC plate, and the procedure described above for construction of calibration curves was followed. The concentration of each drug was calculated from its corresponding regression equation.
(c) Assay of pharmaceutical formulations.-(1) Tablets.-Twenty tablets of each drug were accurately weighed and finely powdered. Amounts equivalent to 500 mg C, 200 mg F, and 200 mg R·HCl were accurately transferred to separate 50 mL volumetric flasks and dissolved in the same solvents that were used to prepare the stock standard solutions; the solutions were filtered and diluted to volume. (2) Ampoules.-Ten ampoules of each drug were mixed together, and volumes equivalent to 500 mg C and 200 mg R·HCl were transferred to separate 50 mL volumetric flasks and diluted to volume with water.
A 2.5 mL aliquot of each of the solutions prepared in (1) or (2) was diluted to 10 mL either with methanol for C and R·HCl or with water for F. The procedure for construction of calibration curves was followed, and the concentration of each drug was calculated from its corresponding regression equation.
Results and Discussion
C, F, and R·HCl are structurally related, H 2 -receptor antagonists that are used for treatment and prevention of duodenal ulcer. They contain sulfur atoms that are susceptible to atmospheric oxidation to the corresponding sulfoxide derivatives (56) , which are pharmacologically inactive (57) . Thus, the development of a method for the determination of these drugs in the presence of their sulfoxide derivatives is of great importance. An HPTLC densitometric technique is suggested for the determination of these drugs in the presence of their In a trial to assess the advantages of HPTLC over TLC, spots were applied at equivalent locations on precoated TLC and HPTLC plates (20 × 20 and 20 × 10 cm, respectively), and the plates were developed with the same solvent systems. On the TLC plates, the spots were applied 2 cm apart, for a maximum of 9 spots per plate. Optimum resolution was reached at 14-16 cm, the diameter of the spots rarely exceeded 8 mm, and the separation time was about 45 min. On the HPTLC plates, spots were spaced 1 cm apart, allowing 18 spots per plate; optimum resolution was reached at 7-8 cm; spot diameter exceeded 4 mm only in very rare cases; and separation time was only 20 min. Thus, HPTLC gives better resolution with a migration distance about 50% of that needed by TLC because the particle size of the HPTLC coating is smaller than that of the TLC coating, and the thickness of the HPTLC coating is slightly thinner than that of conventional layers; thus, the HPTLC coating allows the use of a smaller sample for quantitation, and its superior optical properties provide better accuracy (58) . The HPTLC separations of the intact drugs and their corresponding sulfoxide derivatives are shown in Figure 2 .
In planar chromatography, linearity may cause problems when a wide concentration range is required. The relationship between peak area and amount of substance applied was eval- e Intraday relative standard deviation (n = 3) for samples containing cimetidine at 10 µg/spot, famotidine at 4 µg/spot, or ranitidine hydrochloride at 4 µg/spot. f Interday relative standard deviation (n = 5) for samples containing cimetidine at 45 µg/spot, famotidine at 18 µg/spot, or ranitidine hydrochloride at 18 µg/spot.
uated with linear and polynomial regression functions. Because fitting with the polynomial (second-degree) function gave better correlation and smaller standard deviations, it was, therefore, used for quantitation (59) . The peak areas were plotted versus the corresponding concentration ranges of 5-50 µg/spot for C and 2-20 µg/spot for both F and R·HCl. The following second-order polynomial regression equations were calculated as y = a + bx + cx , x is the concentration in µg/spot, c is the slope, a is the intercept, and r is the correlation coefficient. The mean percentage recoveries were calculated and found to be 100.39 ± 1.33, 99.77 ± 1.30, and 100.09 ± 0.69 for C, F, and R·HCl, respectively.
To assess the stability-indicating efficiency of the proposed method, the sulfoxide derivative of each of the 3 drugs was mixed with the corresponding intact drug in various ratios, and the recoveries were determined; the results are presented in Table 1. The results obtained show that the accuracy of the proposed method is not affected by ≤90% sulfoxide derivative.
Method Validation (60)
The validity and reproducibility of the proposed method were assessed by applying the standard additions technique. Known amounts of standard were added to a fixed amount of sample solution at 5 concentration levels, and the recoveries were calculated. The results are presented in Table 2 . The limit of detection, limit of quantitation, and ruggedness were calculated, and the results are presented in Table 3 . The data obtained from assay validation showed that the proposed method gives results that are precise and reproducible. There was no interference from the sulfoxide derivatives or excipients.
Compared with the official and reported methods for stability testing, HPTLC is relatively inexpensive and capable of rapidly producing quantitative results with high accuracy and precision. The advantages of HPTLC include determination of drugs in the presence of their degradates in many samples under the same conditions; a large number of samples and reference standards can be chromatographed and then quantitatively evaluated on a single plate. No problems are caused by UV-absorbing mobile phase systems because densitometric evaluation is done after the mobile phase has been removed by evaporation.
Conclusions
The proposed method was successfully applied to the simultaneous determination of each of the drugs studied in the presence of the corresponding sulfoxide derivative in bulk powder and dosage forms without any interference from up to 90% derivatives. The method can also be applied to the determination of the sulfoxides as impurities in the bulk drugs or tablets. The calculated t-and F-values were smaller than the theoretical values (Table 4), indicating that there is no significant difference between the proposed and the official methods with respect to accuracy and precision. In addition, the proposed method is simple and rapid. Therefore, it is suitable for quality control and routine analysis. 
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